Fmoc-N-amido-PEG8-acetic acid acts as a protective group-containing ADC linker intermediate, enhancing conjugation flexibility and solubility in antibody-drug conjugates for precise drug delivery.
Structure of 868594-52-9
* For research and manufacturing use only. We do not sell to patients.
Size | Price | Stock | Quantity |
---|---|---|---|
-- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Fmoc-N-amido-PEG8-acetic acid, a versatile linker prevalent in peptide and protein chemistry, showcases a multitude of applications across various fields. Here are four key applications of this compound:
Peptide Synthesis: Positioned at the heart of solid-phase peptide synthesis (SPPS), Fmoc-N-amido-PEG8-acetic acid stands as a crucial instrument for constructing elaborate and extended peptides. The incorporation of a polyethylene glycol (PEG) spacer not only boosts solubility but also mitigates aggregation, streamlining the synthesis and purification processes. Researchers harness this linker to fabricate peptides tailored for drug development, molecular biology inquiries, and therapeutic endeavors.
Protein Conjugation: Acting as a cornerstone in protein conjugation, this compound facilitates the coupling of proteins with an array of biomolecules spanning from drugs to fluorophores to other peptides. Serving as a flexible and hydrophilic bridge, the linker preserves the biological functionality of proteins while enhancing their solubility and stability. This capability proves pivotal in fabricating bioconjugates for targeted drug delivery systems and diagnostic applications.
Drug Delivery Systems: Standing at the forefront of drug delivery innovation, Fmoc-N-amido-PEG8-acetic acid plays a pivotal role in crafting cutting-edge drug delivery platforms, including nanoparticle and liposome formulations. Through the process of PEGylation, the pharmacokinetic properties are bolstered while reducing the immunogenicity of delivery systems. By affixing this linker to therapeutic agents, researchers can precisely modulate drug release profiles, amplifying treatment efficacy and reinforcing patient adherence.
Surface Functionalization: Within the realm of surface chemistry, this linker emerges as a key protagonist in functionalizing biomaterial surfaces to augment biocompatibility and anti-fouling attributes. PEGylation of surfaces, such as implants or biosensors, diminishes protein adsorption and cell adhesion, thereby enhancing device functionality and durability. This advancement elevates the utility of biotechnological devices in medical and analytical settings, underscoring the significance of surface modification in optimizing device performance and longevity with intricate precision.
Catalog | Product Name | CAS | Inquiry |
---|---|---|---|
BADC-00982 | Fmoc-N-amido-PEG2-acetic acid | 166108-71-0 | |
BADC-01112 | Fmoc-N-amido-PEG1-acetic acid | 260367-12-2 | |
BADC-01124 | Fmoc-N-amido-PEG4-acetic acid | 437655-95-3 | |
BADC-01954 | Fmoc-N-amido-PEG6-acetic acid | 437655-96-4 | |
BADC-01142 | Fmoc-N-amido-PEG5-acetic acid | 635287-26-2 |
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.